{"organizations": [], "uuid": "e4b64a284a220beabe06909cf02327910ad7dbd1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ait-therapeutics-announces-further/brief-ait-therapeutics-announces-further-data-from-its-no-ntm-abscessus-phase-2-clinical-trial-idUSASB0C1OI", "country": "US", "domain_rank": 408, "title": "AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.76, "site_type": "news", "published": "2018-01-22T21:20:00.000+02:00", "replies_count": 0, "uuid": "e4b64a284a220beabe06909cf02327910ad7dbd1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ait-therapeutics-announces-further/brief-ait-therapeutics-announces-further-data-from-its-no-ntm-abscessus-phase-2-clinical-trial-idUSASB0C1OI", "ord_in_thread": 0, "title": "AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "ait therapeutics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 20 PM / Updated 17 minutes ago BRIEF-AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial Reuters Staff 1 Min Read \nJan 22 (Reuters) - Ait Therapeutics Inc: \n* AIT THERAPEUTICS ANNOUNCES FURTHER DATA FROM ITS NO-NTM ABSCESSUS PHASE 2 CLINICAL TRIAL IN NONTUBERCULOUS MYCOBACTERIA (NTM) PATIENTS  ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-22T21:20:00.000+02:00", "crawled": "2018-01-22T15:32:35.012+02:00", "highlightTitle": ""}